Incidence and prevalence of coccidioidomycosis in patients with end-state liver disease

Liver Transplantation

Volumn 9, Issue 8, 2003, Pages 843-850

  Blair, Janis E ^a   Balan, Vijayan ^a   Douglas, David D ^a   Hentz, Joseph G ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; FLUCONAZOLE; KETOCONAZOLE; PREDNISONE; STEROID;

ARTICLE; AUTOIMMUNE HEPATITIS; AWARENESS; COCCIDIOIDOMYCOSIS; COMORBIDITY; ENDEMIC DISEASE; HUMAN; INCIDENCE; LIVER FAILURE; LIVER TRANSPLANTATION; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SYMPTOM; UNITED STATES;

EID: 0042062487     PISSN: 15276465     EISSN: None     Source Type: Journal    
DOI: 10.1053/jlts.2003.50125     Document Type: Article

References (37)

1. Pappagianis D. Epidemiology of coccidioidomycosis. In: Stevens DA (ed). Coccidioidomycosis: A text. New York: Plenum Medical Book, 1980:63-85.
2. Galgiani JN. Coccidioidomycosis. West J Med 1993;159:153-171.
3. Catanzaro A, Drutz DJ. Primary coccidioidomycosis. In: Stevens DA (ed). Coccidioidomycosis: A text. New York: Plenum Medical, 1980:139-145.
4. Deresinski SC, Stevens DA. Coccidioidomycosis in compromised hosts: Experience at Stanford University Hospital. Medicine (Baltimore) 1975;54:377-395.
5. Knapp WA, Seeley TT, Ruebner BH. Fatal coccidioidomycosis: Report of two cases. Calif Med 1972;116:86-90.
6. Bouza E, Dreyer JS, Hewitt WL, Meyer RD. Coccidiodal meningitis: An analysis of thirty-one cases and review of the literature. Medicine (Baltimore) 1981;60:139-172.
7. Winn WR, Finegold SM, Huntington RW. Coccidioidomycosis with fungemia. In: Ajello L (ed). Coccidioidomycosis. Tucson, AZ: University of Arizona, 1967:93-109.
8. Calhoun DL, Galgiani JN, Zukoski C, Copeland JG. Coccidioidomycosis in recent renal or cardiac transplant recipients. In: Einstein HE, Catanzaro A (eds). Coccidioidomycosis: Proceedings of the Fourth International Conference on Coccidioidomycosis, San Diego, CA, 14-17 March, 1984. Washington, DC; National Foundation for Infectious Diseases, 1985:312-318.
9. Hall KA, Sethi GK, Rosado LJ, Martinez JD, Huston CL, Copeland JG. Coccidioidomycosis and heart transplantation. J Heart Lung Transplant 1993;12:525-526.
10. Hall KA, Copeland JG, Zukoski CF, Sethi GK, Galgiani JN. Markers of coccidioidomycosis before cardiac or renal transplantation and the risk of recurrent infection. Transplantation 1993; 55:1422-1424.
11. Galgiani JN. Coccidioidomycosis. Curr Clin Top Infect Dis 1997;17:188-204.
12. Smithline N, Ogden DA, Cohn AI. Disseminated coccidioidomycosis in renal transplant patients. In: Ajello L (ed). Coccidioidomycosis: Current clinical and diagnostic status: A comprehensive reference for the clinician and investigator: Selected papers from the Third International Coccidioidomycosis Symposium, Tucson, Arizona. Miami: Symposium Specialists, 1977: 201-206.
13. Cohen IM, Galgiani JN, Potter D, Ogden DA. Coccidioidomycosis in renal replacement therapy. Arch Intern Med 1982;142: 489-494.
14. Holt CD, Winston DJ, Kubak B, Imagawa DK, Martin P, Goldstein L, et al. Coccidioidomycosis in liver transplant patients. Clin Infect Dis 1997;24:216-221.
15. Blair JE, Logan JL. Coccidioidomycosis in solid organ transplantation. Clin Infect Dis 2001;33:1536-1544.
16. Palmer DF. Serodiagnosis of mycotic diseases. Springfield, IL: Thomas, 1977.
17. Wiesner RH, McDiarmid SV, Kamath PS, Edwards EB, Malinchoc M, Kremers WK, et al. MELD and PELD: Application of survival models to liver allocation. Liver Transpl 2001;7:567-580.
18. Roberts PL, Knepshield JH, Wells RF. Coccidioides as an opportunist. Arch Intern Med 1968;121:568-570.
19. DeFelice R, Wieden MA, Galgiani JN. The incidence and implications of coccidioidouria. Am Rev Respir Dis 1982;125:49-52.
20. Farness OJ. Some unusual aspects of coccidioidomycosis. In: Ajello L (ed). Coccidioidomycosis. Tucson, AZ: University of Arizona, 1967:23-24.
21. Byrne WR, Dietrich RA. Disseminated coccidioidomycosis with peritonitis in a patient with acquired immunodeficiency syndrome: Prolonged survival associated with positive skin test reactivity to coccidioidin. Arch Intern Med 1989;149:947-948.
22. Clinical pathological conference, R.E. Thomason General Hospital, El Paso. Southwest Med 1968;49:70-75.
23. Salkin D. Clinical examples of reinfection in coccidioidomycosis. Am Rev Respir Dis 1967;95:603-611.
24. Blair JE, Douglas DD, Mulligan DC. Early results of targeted prophylaxis for coccidioidomycosis in patients undergoing orthotopic liver transplantation within an endemic area. Transpl Infect Dis 2003;5:1-6.
25. Rosenstein NE, Emery KW, Werner SB, Kao A, Johnson R, Rogers D, et al. Risk factors for severe pulmonary and disseminated coccidioidomycosis: Kern County, California, 1995-1996. Clin Infect Dis 2001;32:708-715.
26. Henrickson RV, Biberstein EL. Coccidioidomycosis accompanying hepatic disease in two Bengal tigers. J Am Vet Med Assoc 1972;161:674-677.
27. Leake JA, Mosley DG, England B, Graham JV, Plikaytis BD, Ampel NM, et al. Risk factors for acute symptomatic coccidioidomycosis among elderly persons in Arizona, 1996-1997. J Infect Dis 2000;181:1435-1440.
28. Adams HG, Jordan C. Infections in the alcoholic. Med Clin North Am 1984;68:179-200.
29. Thomas HC, Singer CR, Tilney NL, Folch H, MacSween RN. The immune response in cirrhotic rats. Antigen distribution, humoral immunity, cell-mediated immunity and splenic suppressor cell activity. Clin Exp Immunol 1976;26:574-582.
30. Czlonkowska A, Milewski B. Immunological observations on patients with Wilson's disease. J Neurol Sci 1976;29:411-421.
31. Goihman-Yahr M, Molina T, Sam Martin B, Pereira J, de Roman A, de Gomez MH, Villegas JJ. Polymorphonuclear leukocyte functions in psoriasis. Int J Dermatol 1988;27:633-637.
32. Par A, Bajtai G, Barna K, Ambrus M, Kovacs M, Balazs M, et al. Cellular immune responses and lymphocyte populations in chronic hepatitis. Acta Med Acad Sci Hung 1979;36:31-43.
33. Ponzetto A, Arrigoni A. Alteration in cell-mediated immunity in patients with chronic active hepatitis. I: lymphocyte subpopulations. G Batteriol Virol Immunol 1979;72:28-32.
34. French SW, Burbige EJ, Tarder G, Bourke E, Harkin CG, Denton T. Lymphocyte sequestration by the liver in alcoholic hepatitis. Arch Pathol Lab Med 1979;103:146-152.
35. Smith WI Jr, Van Thiel DH, Whiteside T, Janoson B, Magovern J, Puet T, Rabin BS. Altered immunity in male patients with alcoholic liver disease: Evidence for defective immune regulation. Alcohol Clin Exp Res 1980;4:199-206.
36. Kawanishi H, Tavassolie H, MacDermott RP, Sheagren JN. Impaired concanavalin A-inducible suppressor T-cell activity in active alcoholic liver disease. Gastroenterology 1981:80: 510-517.
37. Snyder N, Bessoff J, Dwyer JM, Conn HO. Depressed delayed cutaneous hypersensitivity in alcoholic hepatitis. Am J Dig Dis 1978;23:353-358.